Breast Cancer Screening: Screening Management:: A. Dci
Breast Cancer Screening: Screening Management:: A. Dci
Breast Cancer Screening: Screening Management:: A. Dci
Routine Mammog
ram and Management by triple FNA
screening Biopsy diagnosis or biopsy
biopsy B
Observe
Invasive Non-invasiv A. DCI
S
Breast CA Metastatic:
- palliative
Follow-up:
* History; eliciting symptoms; PE every 3-6months
for 3 years; every 6-12 months for 2 years; then
annually
* Breast self-exam monthly Stage III:
* Mammography annually Early-stage breast CA: - locally advanced: may do surgery
* Pelvic exam annually - lumpectomy - with chest wall involvement,
* Ongoing px education about symptoms of - adjuvant systemic therapies: inflammatory breast CA, CA w/ large
recurrence 1. Chemotherapy matted axillary LN: mastectomy then
* Ongoing coordination of care 2. Endocrine radiotherapy to chest wall or to the
* ongoing assessment of side effects if on 3. Anti-HER2 breast after tumor excision; regional LN
endocrine therapy therapies treatment
* ECG if on trastuzumab every 3 months; - adjuvant anti-HER2 and endocrine
discontinue when trastuzumab therapy complete therapies, as appropriate
1